Presence and resistance of Streptococcus agalactiae in vaginal specimens of pregnant and adult non-pregnant women and association with other aerobic bacteria;Zastupljenost i rezistencija Streptococcus agalactiae, izolovanih iz vaginalnih uzoraka kod trudnica i žena odrasle dobi koje nisu trudne, te njegova udruženost s drugim aerobnim bakterijama

Medicinski Glasnik

Volumn 14, Issue 1, 2017, Pages 98-105

  Numanović, Fatima ^a   Smajlović, Jasmina ^a   Gegić, Merima ^a   Delibegović, Zineta ^a   Bektaš, Sabaheta ^b   Nurkić, Jasmina ^c   Halilović, Emir ^a  

^a UNIVERSITY CLINICAL CENTER TUZLA   (Bosnia and Herzegovina)

^b Health Center of Sarajevo Canton   (Bosnia and Herzegovina)

^c MINISTRY OF HEALTH   (Kuwait)

Author keywords

Bacterial infections; Reproductive tract infections; Vaginal diseases

Indexed keywords

AMPICILLIN; CEFEPIME; CEFOTAXIME; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; LINEZOLID; VANCOMYCIN; ANTIINFECTIVE AGENT;

AEROBIC BACTERIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; DISK DIFFUSION; FEMALE; GENITAL TRACT INFECTION; HUMAN; NONHUMAN; PREGNANCY; PREGNANT WOMAN; PREVALENCE; STREPTOCOCCUS AGALACTIAE; ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; BOSNIA AND HERZEGOVINA; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDY; STREPTOCOCCAL INFECTIONS; VAGINA; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIA, AEROBIC; BOSNIA AND HERZEGOVINA; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; PROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINA; YOUNG ADULT;

EID: 85014084774     PISSN: 18400132     EISSN: 18402445     Source Type: Journal    
DOI: 10.17392/876-16     Document Type: Article

References (30)

1. Rajagopal L. Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiol 2009; 4:201-21.
2. Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis 2005; 41:839-47.
3. Landwehr-Kenzel S, Henneke P. Interaction of Streptococcus agalactiae and cellular innate immunity in colonization and disease. Front Immunol 2014; 5:1-11.
4. Maisey HC, Doran KS, Nizet V. Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev Mol Med 2008; 10:e27.
5. Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, Harrison LH, Lynfield R, Mohle-Boetani J, Zansky S, Albanese BA, Stefonek K, Zell ER, Jackson D, Thompson T, Schrag SJ. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 2009; 49:85-92.
6. Simoes JA, Aoutcheva AA, Heimler I, Faro S. Antibiotic resistance patterns of group B streptococcal clinical isolates. Infect Dis Obstet Gynecol 2004; 12:1-8.
7. Muller-Vranješ A, Puntarić D, Čuržik D, Šijanović S, Topolovec Z, Kasač Z, Miškulin M. Prevalence and significance of vaginal group B Streptococcus colonization in pregnant women from Osijek, Croatia Coll Antropol 2011; 35:21-6.
8. Mavenyengwa RT, Afset JE, Schei B, Berg S, Caspersen T, Bergseng H, Moyo SR. Group B Streptococcus colonization during pregnancy and maternal-fetal transmission in Zimbabwe. Acta Obstet Gynecol Scand 2010; 89:250-5.
9. Arif D, Urehkar AD, Kore A, Chaundhary BL, Nissar J, Singh S. Prevalence of Streptococcus agalactiae in pregnant women and it antibiotic sensitivity pattern. Int J Curr Microbiol App Sci 2015; 4:315-20.
10. Garland SM, Cottrill E, Markowski L, Pearce C, Clifford V, Ndisang D, Kelly N, Daley AJ. 2011. Antimicrobial resistance in group B streptococcus: the Australian experience. J Med Microbiol 2011; 60:230-5.
11. Helmig R, Halaburt JT, Uldbjert M, Thomsen AC, Stenderup A. Increased cell adherence of group B streptococci from preterm infants with neonatal sepsis. Obstet Gynecol 1990; 76:825-7.
12. Hansen SM, Uldbjerg N, Kilian M, Sørensen UBS. Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their Infants. J Clin Microbiol 2004; 42:83-9.
13. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Center for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease- revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59:1-36.
14. Strus M, Pawlik D, Brzychczy-Wloch M, Gosiewski T, Rytlewski K, Lauterbach R, Heczko PB. Group B streptococcus colonization of pregnant women and their children observed in obstetric and neonatal wards of the University Hospital in Krakow, Poland. J Med Microbiol 2009; 58:228-33.
15. Centers for Disease Control and Prevention. Early-onset group B streptococcal disease-United States, 1998-1999. MMWR Morb Mortal Wkly Rep 2000; 49:793-6.
16. Pinheiro S, Radhouani H, Coelho C, Gonçalves A, Carvalho E, Carvalho JA, Ruiz-Larrea F, Torres C, Igrejas G, Poeta P. Prevalence and mechanisms of erythromycin resistance in Streptococcus agalactiae from healthy pregnant women. Microb Drug Resist 2009; 15:121-4.
17. World Health Organization. Women and health: today’s evidence tomorrow’s agenda.Geneva, Switzerland: WHO Press, 2009.
18. th Edition. Washington, DC, USA: ASM Press, 2015.
19. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility testing - 20th informational supplement. Approved Standard M100-S20. CLSI, Wayne, PA, USA, 2010.
20. Larsen B, Monif GR. Understanding the bacterial flora of the female genital tract. Clin Infect Dis 2001; 32:e69-e77.
21. Reid G, Burton J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect 2002; 4:319-24.
22. Ronnqvist PD, Forsgren-Brusk UB, Grahn-Hakansson EE. Lactobacilli in the female genital tract in relation to other genital microbes and vaginal pH. Acta Obstet Gynecol Scand 2006; 85:726-35.
23. Carson HM, LaPoint PG, Monif GRG. Interrelationships within the bacterial flora of the female genital tract. Infect Dis Obstet Gynecol 1997; 5:305–9.
24. Donders G, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. Br J Obstet Gynecol 2002; 109:34-43.
25. Numanović F, Hukić M, Nurkić M, Gegić M, Delibegović Z, Imamović A, Pašić S. Bacterial vaginosis presence in sexually active women in Tuzla Canton area. BJBMS 2008; 8:323-30.
26. Shabayek SA, Abdalla SM, Abouzeid AM. Vaginal carriage and antibiotic susceptibility profile of group B Streptococcus during late pregnancy in Ismailia, Egypt. J Infect Public Health 2009; 2:86-90.
27. Arisoy AS, Altinişik B, Tünger O, Kurutepe S, Ispahi C. Maternal carriage and antimicrobial resistance profile of group B Streptococcus. Infection 2003; 31:244-6.
28. El Beitune P, Duarte G, Leite Maffei CM. Colonization by Streptococcus agalactiae during pregnancy: maternal and perinatal prognosis. BJID 2005; 9:276-82.
29. Eschenbach DA. Specific bacterial infections: group B streptococcus. The Global Library of Women’s Medicine. http://www.glowm.com/section_view/heading/Specific%20Bacterial%20Infections:%20Group%20 B%20Streptococcus/item/179 (27 February 2016).
30. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, Stefonek KR, Albanese BA, Zell ER, Schuchat A, Schrag SJ; Active Bacterial Core surveillance/Emerging Infections Program Network. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008; 299:2056-65.